
Chidinma (Chima-Okereke) Chima-Melton MD MBA, FCCP (She/Her)
Asthma & COPD, Critical Care Medicine, Interstitial Lung Diseases
Medical Director, Pulmonologist, Intensivist
Join to View Full Profile
1145 W Redondo Beach BlvdGardena, CA 90247
Dr. Chima-Melton is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Chidinma (Chima-Okereke) Chima-Melton is a pulmonologist based in Gardena, CA, with subspecialties in asthma and COPD, critical care medicine, and interstitial lung diseases. She completed her fellowship in Pulmonary Disease and Critical Care Medicine at Cedars-Sinai Medical Center and her residency in Internal Medicine at Yale-New Haven Medical Center. Dr. Chima-Melton graduated from Stony Brook University Health Sciences Center School of Medicine in 2010. Her published research covers topics such as cardiology quality improvement, intersectionality in healthcare, respiratory vaccines, and COVID-19 treatment outcomes, with several studies cited in the medical community.
Education & Training
Cedars-Sinai Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2013 - 2016
Yale-New Haven Medical CenterResidency, Internal Medicine, 2010 - 2013
Stony Brook University Health Sciences Center School of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2013 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Lower mortality risk associated with remdesivir plus corticosteroids vs corticosteroids alone for the treatment of patients hospitalized with SARS-CoV-2 infection in t...Alpesh N Amin, Thomas Oppelt, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton
American Journal of Health-System Pharmacy. 2026-04-11 - Real-world effectiveness of remdesivir in immunocompromised patients hospitalized due to SARS-CoV-2 Infection: Insights to inform pharmacy practice.Andre C Kalil, Chidinma Chima-Melton, Emi Naslazi, Heribert Ramroth, Alpesh N Amin
American Journal of Health-System Pharmacy. 2026-04-11 - 3 citationsImplementing a Cardiology Quality Incentive Program to Improve Guideline-Directed Medical Therapy.David J Cho, Pooya I Bokhoor, Anna Dermenchyan, Nicholas Brownell, Nina Lou Delavin
JACC. Advances. 2025-07-01
Press Mentions
Remdesivir Cuts Risk of Mortality, Hospital Readmission in Hospitalized COVID-19 PatientsFebruary 22nd, 2023
Veklury® (Remdesivir) Reduced Risk of Mortality in Hospitalized COVID-19 Patients Across All Variant Time Periods in a Real World Study of More Than 500,000 Hospitalized PatientsFebruary 21st, 2023
Hyperbaric Oxygen Resolves COVID-19 Breathing Problems Much Faster Than Standard TherapyJanuary 11th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









